EP-1206: FDG-PET/CT predictive parameters of early response after SABR for lung oligometastases

FDG PETCT in colorectal cancer

Colorectal cancer represents the second most common malignancy worldwide, with approximately one million newly diagnosed cases each year, and is the fourth leading cause of cancer mortality. This article provides an overview of the role of FDG (fluorodeoxyglucose) PET (positron emission tomography) CT (computed tomography) for assessment in patients with colorectal cancer. A summary of key lear...

Dosemetric Parameters Predictive of Rib Fractures after Proton Beam Therapy for Early-Stage Lung Cancer.

Proton beam therapy (PBT) is the preferred modality for early-stage lung cancer. Compared with X-ray therapy, PBT offers good dose concentration as revealed by the characteristics of the Bragg peak. Rib fractures (RFs) after PBT lead to decreased quality of life for patients. However, the incidence of and the risk factors for RFs after PBT have not yet been clarified. We therefore explored the ...

SABR in early operable lung cancer: time for evidence.

In The Lancet Oncology, Joe Chang and colleagues report the combined results of two randomised trials (STARS and ROSEL) comparing stereotactic ablative radiotherapy (SABR) with surgery for early-stage non-small-cell lung cancer, both of which were halted early because of slow recruitment. We congratulate the investigators for publishing the results and for being prepared to merge their data in ...

F 18 FDG PETCT detection for liver metastases

Reduced-dose [F]-FDG PETCT scanning with current generation PETCT systems